Novo Nordisk Price Target 2025

Posted by

Novo Nordisk Price Target 2025 – Novo nordisk stock price prediction 2025. Novo nordisk stock price predictions for 2025, 2026, 2027 using artificial intelligence. Novo nordisk stock price forecast for march 2025. Novo nordisk stock prediction for april 2025.

This indicates an +189.41% increase from the last price of $90.86. Maximum price 104.51, minimum 76.99. In may, the positive dynamics for novo nordisk a/s shares will prevail with possible monthly volatility of 11.220% volatility is expected. Looking ahead to 2025, analysts predict that novo nordisk stock could experience volatility.

Novo Nordisk Price Target 2025

Novo Nordisk Price Target 2025

Novo Nordisk Price Target 2025

The weighted average target price per novo nordisk share in may 2025 is: Novo nordisk share price prediction for next months and years. Positive dynamics for novo nordisk shares will prevail with possible volatility of 0.993%.

Cantor fitzgerald reiterated an overweight rating and set a $160.00 price objective on shares of novo nordisk a/s in a research report on wednesday, november 6th. At the end 95.53 dollars, change for march 5.4%. For 2027, stockscan’s analyst expects the average price target for novo nordisk adr (nvo) is $262.96, with a high forecast of $285.78 and a low forecast of $240.13.

According to current forecasts, the stock is expected to trade between $76.71 and $109.20, representing. What is novo nordisk a/s’s forecast for 2025? The forecast for beginning 90.65 dollars.

How much will novo nordisk shares cost tomorrow? Bmo capital markets lowered their target price on shares of novo nordisk a/s from $156.00 to $105.00 and set an outperform rating on the stock in a report on monday, december 23rd. Averaged novo nordisk stock price for the month 91.92.

NVO Stock Forecast 20252035 Outlook » Exla Resources

NVO Stock Forecast 20252035 Outlook » Exla Resources

Novo Nordisk A/S Stock Forecast up to 100.515 USD! NVO Stock Price Prediction, LongTerm & ShortTerm Share Revenue Prognosis with Smart Technical Analysis

Novo Nordisk A/S Stock Forecast up to 100.515 USD! NVO Stock Price Prediction, LongTerm & ShortTerm Share Revenue Prognosis with Smart Technical Analysis

Novo Nordisk Stock (NYSENVO) Can Wegovy Justify Its Valuation? Nasdaq

Novo Nordisk Stock (NYSENVO) Can Wegovy Justify Its Valuation? Nasdaq

Earnings To Watch Novo Nordisk AS (OCSENOVO B) Reports Q3 2024

Earnings To Watch Novo Nordisk AS (OCSENOVO B) Reports Q3 2024

Novo Nordisk CEO on earnings Very bullish on 2025 despite demand concerns

Novo Nordisk CEO on earnings Very bullish on 2025 despite demand concerns

Novo Nordisk A/S (NVO) Price Prediction and Forecast 20252030 24/7 Wall St.

Novo Nordisk A/S (NVO) Price Prediction and Forecast 20252030 24/7 Wall St.

Novo Nordisk Bears Not Done With Stock Yet EWM Interactive

Novo Nordisk Bears Not Done With Stock Yet EWM Interactive

NVO Stock Forecast 20252035 Outlook » Exla Resources

NVO Stock Forecast 20252035 Outlook » Exla Resources

Don't Worry About Novo Nordisk's Premium Stock Price. It's Still a Buy. The Motley Fool

Don't Worry About Novo Nordisk's Premium Stock Price. It's Still a Buy. The Motley Fool

Novo Nordisk A/S (NVO) Equity Research, Stock Forecast & Insights on Wegovy and Ozempic Maker Investingstrategy.co.uk

Novo Nordisk A/S (NVO) Equity Research, Stock Forecast & Insights on Wegovy and Ozempic Maker Investingstrategy.co.uk

Novo Nordisk Poised for ShortTerm Gains, while Eli Lilly Promises Stronger LongTerm Growth Nasdaq

Novo Nordisk Poised for ShortTerm Gains, while Eli Lilly Promises Stronger LongTerm Growth Nasdaq

Novo Nordisk Stock Slides Before Q4 Earnings Analysts Still See 68 Upside Novo Nordisk (NYSEN
VO) Benzinga

Novo Nordisk Stock Slides Before Q4 Earnings Analysts Still See 68 Upside Novo Nordisk (NYSENVO) Benzinga

Wall Street analysts discuss Novo Nordisk stock outlook for 2025 By

Wall Street analysts discuss Novo Nordisk stock outlook for 2025 By

NVO Stock Forecast 20252035 Outlook » Exla Resources

NVO Stock Forecast 20252035 Outlook » Exla Resources

Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows (NYSENVO) Seeking Alpha

Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows (NYSENVO) Seeking Alpha

Leave a Reply